A detailed history of Strs Ohio transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Strs Ohio holds 7,700 shares of CDMO stock, worth $91,861. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,700
Previous 7,700 -0.0%
Holding current value
$91,861
Previous $54,000 61.11%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$6.34 - $9.28 $47,550 - $69,600
7,500 Added 3750.0%
7,700 $54,000
Q1 2022

Apr 21, 2022

SELL
$16.63 - $27.73 $36,586 - $61,006
-2,200 Reduced 91.67%
200 $4,000
Q4 2021

Jan 24, 2022

SELL
$20.7 - $34.18 $869,400 - $1.44 Million
-42,000 Reduced 94.59%
2,400 $70,000
Q3 2021

Oct 22, 2021

BUY
$19.05 - $28.32 $19,050 - $28,320
1,000 Added 2.3%
44,400 $957,000
Q2 2021

Jul 26, 2021

SELL
$18.93 - $25.65 $225,267 - $305,235
-11,900 Reduced 21.52%
43,400 $1.11 Million
Q1 2021

Apr 23, 2021

SELL
$11.86 - $21.77 $183,830 - $337,435
-15,500 Reduced 21.89%
55,300 $1.01 Million
Q4 2020

Jan 25, 2021

SELL
$7.25 - $11.76 $40,600 - $65,856
-5,600 Reduced 7.33%
70,800 $817,000
Q3 2020

Dec 14, 2020

SELL
$6.53 - $8.6 $119,499 - $157,380
-18,300 Reduced 19.32%
76,400 $582,000
Q2 2020

Jul 23, 2020

SELL
$4.11 - $6.78 $28,770 - $47,460
-7,000 Reduced 6.88%
94,700 $621,000
Q1 2020

Apr 23, 2020

BUY
$3.15 - $7.39 $56,700 - $133,020
18,000 Added 21.51%
101,700 $519,000
Q4 2019

Jan 24, 2020

BUY
$5.01 - $8.16 $249,999 - $407,184
49,900 Added 147.63%
83,700 $641,000
Q3 2019

Oct 21, 2019

BUY
$5.07 - $7.08 $92,781 - $129,564
18,300 Added 118.06%
33,800 $179,000
Q4 2018

Jan 23, 2019

BUY
$4.04 - $6.75 $62,620 - $104,625
15,500 New
15,500 $63,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $742M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.